GHRL and cancer: Anamorelin, an oral ghrelin-like agent, reportedly improved body weight and anorexia-related symptoms in cancer patients [29] and we also reported that insufficient protein intake was a poor prognostic factor in patients with unresectable PC receiving chemotherapy [30].